Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil.
スポンサーリンク
概要
- 論文の詳細を見る
Characteristics of the interaction of verapamil with serotonin receptors were studied in rat brain membranes using a radioligand binding technique. While verapamil competed for the [<SUP>3</SUP>H]ketanserin binding sites at low concentrations with the K<SUB>i</SUB> value of 0.41 μM, much higher concentrations were needed to inhibit the binding of [<SUP>3</SUP>H]serotonin to its binding sites, indicating higher affinity of verapamil binding for 5-HT<SUB>2</SUB> than 5-HT<SUB>1</SUB> receptors. The inhibitory action of verapamil on the [<SUP>3</SUP>H]ketanserin binding was stereoselective; the (-)isomer was about ten times more potent than the (+)isomer. The interaction of verapamil with [<SUP>3</SUP>H]ketanserin was competitive and reversible. While D600, a verapamil derivative, also competed for the [<SUP>3</SUP>H]ketanserin binding sites, nifedipine and nicardipine had practically no ability to inhibit the ligand binding to 5-HT<SUB>1</SUB> or 5-HT<SUB>2</SUB> receptors. Although diltiazem competed for 5-HT<SUB>2</SUB> receptors, the affinity was much less than verapamil and D600.
- 公益社団法人 日本薬理学会の論文
著者
-
Adachi Hideyuki
Department Of Cardiovascular Disease Research Eisai Tsukuba Research Laboratories
-
Shoji Tadao
Department of Applied Chemistry, Faculty of Engineering, Keio University
関連論文
- DIFFERENT MODES OF ACTION OF CLONIDINE ON ISOLATED CANINE VEINS
- COMPARISON OF THROMBOLYTIC EFFECT OF A NOVEL MODIFIED TISSUE PLASMINOGEN ACTIVATOR, E-6010, AND A NATIVE TISSUE PLASMINOGEN ACTIVATOR IN PIGS WITH OCCLUSIVE CORONARY THROMBOSIS : Coronary Thrombolysis : 53 Annual Scientific Meeting, Japanese Circulation S
- CARDIOHEMODYNAMIC EFFECTS OF A NOVEL SELECTIVE AND POTENT PHOSPHODIESTERASE V INHIBITOR, E4021, IN THE PIG
- Proton Magnetic Resonance Studies on Specifically Deuterated Sucrose Acetates
- Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil.